Professor Sir Chris Evans

One of the world’s leading biotech entrepreneurs and scientists, Prof. Sir Chris has spent 37+ years at the forefront of his trade, turning scientific discoveries into products and services that have directly benefited the lives of millions of people around the world.

He started his first company, Enzymatix in 1987 where he quickly developed surfactants which went on to save the lives of millions of premature babies by enabling their lungs to open. 

In 1995, he became an OBE and by 2001, he was the youngest scientist to be knighted for services to bioscience, enterprise and advisory roles to the UK and global governments. Finding more positive outcomes and options for those affected by cancer has always been a focus for Prof. Sir Chris. 

In 2018 he founded the cancer drug development company, Ellipses Pharma, alongside the UK charity, Cancer Awareness Trust, with the purpose of building Cancer Platform.  

In 2022, Prof. Sir Chris launched EDX Medical to focus on creating cancer prevention and diagnostics solutions. 

Prof. Sir Chris is also the founder of Evamore Music (formerly Evamore Records) which now sits as part of the Cancer Awareness Trust family.